Posted by Michael Wonder on 08 Jun 2023
Proposal to widen access to intravenous trastuzumab and change the funded brand
8 June 2023 - The proposal would also give more New Zealanders funded access to intravenous trastuzumab.
From 1 December 2023, people with stomach (gastric) cancer who meet certain funding criteria would be able to access funded intravenous trastuzumab.
